We presented the first direct evidence that Ltf could attenuate adverse cardiac remodeling and improve cardiac function via inhibiting excessive cardiac fibrosis post-MI, mainly through suppressing the activation of mTORC1/S6K/eIF-4B axis in myofibroblasts. Here, EIF4B is linked to fibrosis.